Peptic Ulcer Disease
📧 Sign up to get email alerts when something new happens for Peptic Ulcer Disease.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2014-11-05FDA Approved: PROTONIX I.V. — Supplemental Application (Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.)
The FDA approved a supplemental NDA for Protonix IV (pantoprazole sodium) from Wyeth Pharmaceuticals (Pfizer), confirming/adding the intrave…
-
FDA approval · 2014-10-31FDA Approved: OMEPRAZOLE — Supplemental Application (Sandoz Inc)
FDA approved a supplemental application for omeprazole from Sandoz Inc, authorizing continued manufacture and sale of a generic omeprazole p…
-
CLINICAL_TRIALS research · 2014-09-22Clinical Trial Update: Multicenter Validation on Predicting Mortality for Patients With Bleeding Peptic Ulcers
A multicenter validation study assessing a mortality-prediction model for patients with peptic ulcer disease presenting with gastrointestina…
-
CLINICAL_TRIALS trial_result · 2014-09-16Clinical Trial Update: Argon Plasma Coagulation for Bleeding Peptic Ulcers [Phase 4]
A Phase 4 clinical trial evaluating argon plasma coagulation for bleeding peptic ulcers has completed.
-
CLINICAL_TRIALS trial_result · 2014-07-24Clinical Trial Update: The Association With Peptic Ulcer Disease and Hepatic Vein Pressure Gradient
A completed clinical trial investigated the association between peptic ulcer disease and hepatic venous pressure gradient in individuals wit…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2014-07-15Clinical Trial Update: Risk of Uncomplicated Peptic Ulcer in the General Population
Completed clinical trial update examining the risk of uncomplicated peptic ulcers in the general population. The snippet does not identify a…
-
CLINICAL_TRIALS trial_result · 2014-06-03Clinical Trial Update: Efficacy/Safety Study as H. Pylori Eradication of Triple Therapy for 7 Days Treatment [Phase 3]
This Phase 3 trial evaluated the efficacy and safety of a 7-day triple therapy for Helicobacter pylori eradication in peptic ulcer disease a…
-
FDA approval · 2014-05-30FDA Approved: FAMOTIDINE — Original Application (Akorn)
The FDA approved Akorn's original application for a generic famotidine product, enabling market entry of a competitor to the brand-name drug…
-
FDA approval · 2014-05-28FDA Approved: BISMUTH SUBCITRATE POTASSIUM, METRONIDAZOLE AND TETRACYCLINE HYDROCHLORIDE — Supplemental Application (H2-Pharma, LLC)
FDA approved a supplemental application for the combination drug bismuth subcitrate potassium, metronidazole and tetracycline hydrochloride,…
-
FDA approval · 2014-02-05FDA Approved: BISMUTH SUBCITRATE POTASSIUM, METRONIDAZOLE AND TETRACYCLINE HYDROCHLORIDE — Supplemental Application (H2-Pharma, LLC)
FDA approved a supplemental application for Bismuth Subcitrate Potassium, Metronidazole and Tetracycline Hydrochloride, a combination therap…
-
CLINICAL_TRIALS safety_alert · 2014-01-22Clinical Trial Update: Adverse Events During Upper Gastrointestinal Endoscopy
This clinical trial update reports adverse events observed during upper gastrointestinal endoscopy in patients with peptic ulcer disease and…
-
FDA approval · 2014-01-07FDA Approved: CIMETIDINE — Supplemental Application (Mylan Pharmaceuticals Inc.)
FDA approved a supplemental application for the generic drug cimetidine by Mylan Pharmaceuticals Inc.
-
FDA approval · 2013-12-19FDA Approved: OMEPRAZOLE — Supplemental Application (Sandoz Inc)
The FDA approved a supplemental application for omeprazole from Sandoz Inc, authorizing updates to the approved generic product.
-
FDA label_change · 2013-12-10FDA Approved: PROTONIX DELAYED-RELEASE — Supplemental Application (Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.)
FDA approved a supplemental application for PROTONIX DELAYED-RELEASE (pantoprazole sodium) to update the product labeling. The sponsor is Wy…
-
FDA approval · 2013-10-31FDA Approved: OMEPRAZOLE MAGNESIUM — Supplemental Application (Gericare Pharmaceuticals)
The FDA approved a supplemental application for omeprazole magnesium from Gericare Pharmaceuticals, granting approval for a generic product …
-
CLINICAL_TRIALS research · 2013-10-29Clinical Trial Update: Prevention of Gastric Ulcer Bleeding by Using "Computer-alert" in General Practice [NA]
A clinical trial evaluating whether a computer-alert system used in primary care can prevent gastric ulcer bleeding in patients with peptic …
-
CLINICAL_TRIALS trial_result · 2013-09-27Clinical Trial Update: Clarithromycin Resistant Tailored Therapy [Phase 4]
Phase 4 trial results update on clarithromycin-resistant tailored therapy for Helicobacter pylori infection in peptic ulcer disease; results…
-
CLINICAL_TRIALS trial_result · 2013-09-25Clinical Trial Update: Comparative Study of Autologous Blood Injection Versus Diluted Epinephrine in Treating Actively Bleeding Gastroduodenal Ulcers [NA]
This completed clinical trial compares autologous blood injection with diluted epinephrine for the treatment of actively bleeding gastroduod…
-
FDA label_change · 2013-09-13FDA Approved: GOOD NEIGHBOR PHARMACY OMEPRAZOLE — Supplemental Application (Amerisource Bergen)
The FDA lists a supplemental application for Good Neighbor Pharmacy Omeprazole (omeprazole) from AmerisourceBergen, typically related to lab…
-
FDA approval · 2013-08-14FDA Approved: BISMUTH SUBCITRATE POTASSIUM, METRONIDAZOLE AND TETRACYCLINE HYDROCHLORIDE — Supplemental Application (H2-Pharma, LLC)
FDA approved a supplemental NDA for a bismuth subcitrate potassium, metronidazole, and tetracycline hydrochloride product (NDA 050786) from …
-
CLINICAL_TRIALS trial_result · 2013-06-18Clinical Trial Update: The Risk of Uncomplicated Peptic Ulcer in a Cohort of Secondary Prevention Aspirin Users
The trial update reports on the risk of developing uncomplicated peptic ulcer in a cohort of aspirin users for secondary prevention. The stu…
-
CLINICAL_TRIALS trial_result · 2013-06-11Clinical Trial Update: Safety and Immunogenicity of Chiron's Investigational H. Pylori Vaccine in Healthy Adults [Phase 1]
Phase 1 study reports safety and immunogenicity data for an investigational Helicobacter pylori vaccine in healthy adults.
-
CLINICAL_TRIALS trial_result · 2013-06-04Clinical Trial Update: Efficiency Study of Clarithromycin and Bismuth-containing Quadruple Therapy to Treat H.Pylori [Phase 4]
Phase 4 trial evaluating clarithromycin-based bismuth quadruple therapy for Helicobacter pylori infection in patients with functional dyspep…
-
CLINICAL_TRIALS trial_result · 2013-06-04Clinical Trial Update: Empirical Rescue Therapies of Helicobacter Pylori Infection [Phase 4]
Phase 4 trial update on empirical rescue therapies for Helicobacter pylori infection has completed. The study enrolled patients with functio…
-
FDA approval · 2013-05-17FDA Approved: PANTOPRAZOLE — Supplemental Application (NorthStar RxLLC)
FDA approved a supplemental application for Pantoprazole (ANDA077619) filed by NorthStar RxLLC.